105 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34599427 | Arginase-1 Released into CSF After Aneurysmal Subarachnoid Hemorrhage Decreases Arginine/Ornithine Ratio: a Novel Prognostic Biomarker. | 2022 Jun | 4 |
2 | 35022194 | Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer. | 2022 Jan | 1 |
3 | 35203413 | L-Arginine Depletion Improves Spinal Cord Injury via Immunomodulation and Nitric Oxide Reduction. | 2022 Jan 18 | 1 |
4 | 35281666 | Clinical status, biochemical profile and management of a single cohort of patients with arginase deficiency. | 2022 Mar | 1 |
5 | 35316752 | Arginase: An emerging and promising therapeutic target for cancer treatment. | 2022 May | 2 |
6 | 33025106 | Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases. | 2021 Jan | 2 |
7 | 33232463 | Single Nucleotide Polymorphisms in the Arginase 1 and 2 Genes Are Differentially Associated with Circulating l-Arginine Concentration in Unsupplemented and l-Arginine-Supplemented Adults. | 2021 Apr 8 | 22 |
8 | 33410970 | Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. | 2021 Jun | 1 |
9 | 33500272 | Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth. | 2021 Apr | 2 |
10 | 33524560 | An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway. | 2021 Apr 1 | 2 |
11 | 33754845 | Development of a Novel Label-Free and High-Throughput Arginase-1 Assay Using Self-Assembled Monolayer Desorption Ionization Mass Spectrometry. | 2021 Jul | 1 |
12 | 34131176 | Neutrophils drive endoplasmic reticulum stress-mediated apoptosis in cancer cells through arginase-1 release. | 2021 Jun 15 | 1 |
13 | 34287772 | Safety, PK/PD and preliminary anti-tumor activities of pegylated recombinant human arginase 1 (BCT-100) in patients with advanced arginine auxotrophic tumors. | 2021 Dec | 1 |
14 | 34326456 | Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action. | 2021 Jul 29 | 2 |
15 | 34367736 | Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma. | 2021 | 1 |
16 | 34943588 | Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma. | 2021 Dec 14 | 1 |
17 | 32312763 | Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishmaniasis. | 2020 Jun 22 | 5 |
18 | 32418491 | High-Throughput Fluorescence-Based Activity Assay for Arginase-1. | 2020 Oct | 1 |
19 | 32647818 | Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158. | 2020 | 1 |
20 | 32721242 | Common Variants in the ARG1 Gene Contribute to the Risk of Dilated Cardiomyopathy in the Han Chinese Population. | 2020 Sep | 1 |
21 | 32780724 | Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis. | 2020 Sep 17 | 1 |
22 | 32839531 | Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model. | 2020 Aug 24 | 1 |
23 | 32920160 | Analysis of Cyclooxygenase 2, Programmed Cell Death Ligand 1, and Arginase 1 Expression in Human Pituitary Adenoma. | 2020 Dec | 1 |
24 | 33092030 | Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. | 2020 Oct 20 | 2 |
25 | 33128544 | ARG1 functions as a tumor suppressor in breast cancer. | 2020 Dec 11 | 1 |
26 | 30605863 | Metabolic pathways of L-arginine and therapeutic consequences in tumors. | 2019 Mar | 2 |
27 | 30696923 | Immune control by amino acid catabolism during tumorigenesis and therapy. | 2019 Mar | 2 |
28 | 30797943 | Amino acid metabolism as drug target in autoimmune diseases. | 2019 Apr | 2 |
29 | 30808864 | Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma. | 2019 Feb 26 | 5 |
30 | 30890279 | Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer. | 2019 Jun | 2 |
31 | 31149961 | Myeloid-Derived Suppressor Cells Mediate Immunosuppression After Cardiopulmonary Bypass. | 2019 Aug | 1 |
32 | 31177351 | Nitric oxide production is downregulated during respiratory syncytial virus persistence by constitutive expression of arginase 1. | 2019 Sep | 1 |
33 | 31399282 | Slc6a8-Mediated Creatine Uptake and Accumulation Reprogram Macrophage Polarization via Regulating Cytokine Responses. | 2019 Aug 20 | 1 |
34 | 31646104 | Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response. | 2019 | 2 |
35 | 31690955 | Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope. | 2019 Nov | 2 |
36 | 28374859 | Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. | 2018 Apr | 2 |
37 | 29227812 | Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia. | 2018 Feb | 1 |
38 | 29399404 | Frequent adaptive immune responses against arginase-1. | 2018 | 1 |
39 | 29487337 | Homoarginine and inhibition of human arginase activity: kinetic characterization and biological relevance. | 2018 Feb 27 | 1 |
40 | 29559907 | Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study. | 2018 | 2 |
41 | 30228936 | Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation. | 2018 | 1 |
42 | 27903651 | T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions. | 2017 Jan 6 | 1 |
43 | 28071686 | Identification of temporal genes involved in the mechanisms of spinal cord injury. | 2017 Apr | 1 |
44 | 28119468 | Candida albicans Chitin Increases Arginase-1 Activity in Human Macrophages, with an Impact on Macrophage Antimicrobial Functions. | 2017 Jan 24 | 1 |
45 | 28166447 | Nutrition Support for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. | 2017 Apr | 1 |
46 | 28214225 | A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells. | 2017 Feb 21 | 2 |
47 | 28315470 | The nitric oxide synthase 2 pathway is targeted by both pro- and anti-inflammatory treatments in the immature human intestine. | 2017 Jun 1 | 1 |
48 | 28545736 | Amino-acid sensing and degrading pathways in immune regulation. | 2017 Jun | 2 |
49 | 29055959 | Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome. | 2017 | 1 |
50 | 29110610 | VEGFR1 Signaling Regulates IL-4-Mediated Arginase 1 Expression in Macrophages. | 2017 Dec 7 | 2 |